Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2260916
Max Phase: Preclinical
Molecular Formula: C23H15N3O2
Molecular Weight: 365.39
Molecule Type: Small molecule
Associated Items:
ID: ALA2260916
Max Phase: Preclinical
Molecular Formula: C23H15N3O2
Molecular Weight: 365.39
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=c1onc(-c2ccccc2)c2c(-c3ccccc3)n(-c3ccccc3)nc12
Standard InChI: InChI=1S/C23H15N3O2/c27-23-21-19(20(25-28-23)16-10-4-1-5-11-16)22(17-12-6-2-7-13-17)26(24-21)18-14-8-3-9-15-18/h1-15H
Standard InChI Key: OKDKTIRYVZNQQM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 365.39 | Molecular Weight (Monoisotopic): 365.1164 | AlogP: 4.71 | #Rotatable Bonds: 3 |
Polar Surface Area: 60.92 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.50 | CX LogD: 5.50 |
Aromatic Rings: 5 | Heavy Atoms: 28 | QED Weighted: 0.46 | Np Likeness Score: -0.94 |
1. Bildirici I, Sener A, Tozlu I. (2007) Further derivatives of 4-benzoyl-1,5-diphenyl-1H-pyrazole-3-carboxylic acid and their antibacterial activities, 16 (7): [10.1007/s00044-007-9082-z] |
Source(1):